Genotoxicity induced by arsenic compounds in peripheral human lymphocytes analysed by cytokinesis-block micronucleus assay

被引:46
作者
Colognato, R.
Coppede, F.
Ponti, J.
Sabbioni, E.
Migliore, L.
机构
[1] Univ Pisa, Dept Human & Environm Sci, I-56126 Pisa, Italy
[2] Univ Pisa, Dept Neurosci, I-56126 Pisa, Italy
[3] JRC Ispra, European Commiss, Inst Hlth & Consumer Protect, ECVAM Unit, I-21020 Ispra, VA, Italy
关键词
D O I
10.1093/mutage/gem010
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
This work focuses on the analysis of genotoxic effects on human peripheral lymphocytes exposed in vitro to different arsenic (As) compounds by means of the cytokinesis-block micronucleus assay. The study was carried out by challenging peripheral human lymphocytes with six As compounds in trivalent or pentavalent forms such as arsenite (As-III) and arsenate (As-v) and organoarsenic species such as monomethylarsonous acid (MMAsIII), monomethylarsonic acid (MMAsv), dimethylarsinic acid (DMAsv) and trymethylarsine oxide (TMAO(v)). For As-III and As-v at concentrations of 4 and 32 RM, respectively, an increase of micronuclei (MN) frequency was found. MMAsIII. and MMAsv induced a statistically significant increase of MN frequency at the dose of 2 and 500 mu M, respectively. For DMAsv, no significant increase of MN was observed, although a decrease of the nuclear division index (NDI) was evident, indicating a cytotoxic effect. The genotoxic mechanism of action of MMAsIII was further evaluated by means of fluorescence in situ hybridization analysis. Due to a higher percentage of centromere-positive MN, MMAsIII showed a clear aneuploidogenic property. Finally, for TMAO(v) no genotoxicity was observed up to 1 mM. These results show how speciation is important in determining the genotoxic and cytotoxic effects of As compounds in human peripheral lymphocytes and support the emerging hypothesis that the induction of aneuploidy could be a mechanism by which As exerts its carcinogenic properties.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 47 条
[1]  
Basu A, 2004, CANCER EPIDEM BIOMAR, V13, P820
[2]  
BONASSI S, 1995, CANCER EPIDEM BIOMAR, V4, P671
[3]  
Bonassi S, 2001, ENVIRON MOL MUTAGEN, V37, P31
[4]   Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan [J].
Chen, CJ ;
Hsu, LI ;
Wang, CH ;
Shih, WL ;
Hsu, YH ;
Tseng, MP ;
Lin, YC ;
Chou, WL ;
Chen, CY ;
Lee, CY ;
Wang, LH ;
Cheng, YC ;
Chen, CL ;
Chen, SY ;
Wang, YH ;
Hsueh, YM ;
Chiou, HY ;
Wu, MM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 206 (02) :198-206
[5]   Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan [J].
Chiou, HY ;
Hsueh, YM ;
Hsieh, LL ;
Hsu, LI ;
Hsu, YH ;
Hsieh, FI ;
Wei, ML ;
Chen, HC ;
Yang, HT ;
Leu, LC ;
Chu, TH ;
ChenWu, C ;
Yang, MH ;
Chen, CJ .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 1997, 386 (03) :197-207
[6]   ARSENIC SPECIATION IN THE ENVIRONMENT [J].
CULLEN, WR ;
REIMER, KJ .
CHEMICAL REVIEWS, 1989, 89 (04) :713-764
[7]   Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells [J].
Dopp, E ;
Hartmann, LM ;
Florea, AM ;
von Recklinghausen, U ;
Pieper, R ;
Shokouhi, B ;
Rettenmeier, AW ;
Hirner, AV ;
Obe, G .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 201 (02) :156-165
[8]   Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes [J].
Drobná, Z ;
Waters, SB ;
Walton, FS ;
LeCluyse, EL ;
Thomas, DJ ;
Styblo, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 201 (02) :166-177
[9]   The in vitro micronucleus technique [J].
Fenech, M .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 455 (1-2) :81-95
[10]   Genotoxicity of arsenical compounds [J].
Gebel, TW .
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2001, 203 (03) :249-262